Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Acutaas Chemicals Limited logo

Acutaas Chemicals Limited

ACUTAAS·Pharmaceuticals
  • Nifty 500

Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.

147Announcements
10-09-2026Last filed
23Last 90 days

What Acutaas files

  • Others57
  • Investor Meet36
  • Updates21
  • Important12
  • PPTs8
  • Board Meeting5
Showing Important announcements (12)Clear filter
29-01-2026 · 06:29 pm

Acutaas Chemicals Limited has informed the Exchange regarding 'Annual Sustainability Report of the Company for the FY 2024-25'.

Read the full announcement→
PDF
29-01-2026 · 05:45 pm

Acutaas Chemicals' Board approved robust financial results for the quarter and nine months. Revenue hit ₹391.83 Cr, and profit reached ₹107.36 Cr. Subsidiary AAML invested ₹130.80 Cr for a 75% stake in South Korean JV Indichem Inc., boosting global expansion.

Read the full announcement→
PDF
02-09-2025 · 02:36 pm

Acutaas Chemicals' Board proposed a dividend of Rs. 1.50 per equity share for FY24-25, awaiting shareholder approval. The company will deduct tax from dividend payments. Shareholders are advised to update their records with PAN and bank details for accurate tax processing and timely receipt.

Read the full announcement→
PDF
02-05-2025 · 04:11 pm

Ami Organics Limited has announced a board meeting to approve a final dividend of Rs 1.5 per share (30%) for FY 2024-25, subject to shareholder approval. This signals the company’s focus on returning value to shareholders, reflecting confidence in its operational performance. Dividend payout details will be shared later.

Read the full announcement→
PDF
24-04-2025 · 05:08 pm

A board meeting is scheduled to consider the final dividend for the fiscal year 2024-25, pending approval at the upcoming Annual General Meeting. Additionally, the trading window for designated persons has been closed since April 1, 2025, and will reopen on May 5, 2025. Keep an eye on potential impacts...

Read the full announcement→
PDF